MAPT and Alzheimer disease: Biomarkers of AD-related neurodegeneration are high CSF tau (total or phosphorylated); atrophy on structural MRI in an AD-like topographic pattern (particularly medial temporal structures); and decreased metabolism on FDG-PET in an AD-like topographic pattern [14].